Tag: antiarrhythmic drugs
J&J’s dual-energy ablation catheter deemed safe and effective in first-in-human SmartfIRE...
Johnson & Johnson (J&J) MedTech has today announced 12-month results from the SmartfIRE study, delivered as a late-breaking presentation at the ongoing European Heart...
ESC 2019: Guidelines on supraventricular tachycardias underline pivotal role of catheter...
The European Society of Cardiology (ESC) unveiled guidelines for treatment of supraventricular tachycardia (SVT) on the opening day of its Congress (ESC 2019; 31...
Five surprising messages from this year’s Europe AF
1.
The "ILL-CONCEIVED" pallas study may be relaunched
John Camm
"I want to say just a few quick words about dronedarone", John Camm (St George's University of...
Ablation should be “preferred approach” in drug-resistant ventricular tachycardia
A multicentre, randomised controlled trial has shown that catheter ablation is superior to intensified antiarrhythmic drug therapy in reducing death, appropriate implantable cardioverter defibrillator...